Shanghai Bio-heart Biological Technology Co Ltd Class H 02185
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HK$0.94
- Day Range
- HK$0.90–1.02
- 52-Week Range
- HK$0.90–7.75
- Bid/Ask
- HK$0.90 / HK$0.98
- Shares Outstanding
- 243.42M
- Market Cap
- HK$219.08M
- Volume/Avg
- 105,400 / 92,395
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.10
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Shanghai Bio-heart Biological Technology Co Ltd is engaged in the research and development of bioresorbable scaffold (BRS) products and the renal denervation (RDN) system. The company is a interventional cardiovascular device company in China, and locate in Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. Focused on two therapies, bioresorbable scaffolds (BRS) and renal denervation (RDN), addressing the unmet medical needs of Chinese patients for the treatment of coronary and peripheral artery diseases and uncontrolled hypertension. Currently, the portfolio has three product candidates in various stages of clinical development.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 63
- Website
- http://www.bio-heart.com
Valuation
Metric | 02185 |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 5.10 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | 02185 |
|---|---|
Quick Ratio | 18.17 |
Current Ratio | 23.75 |
Interest Coverage | −8.90 |
Quick Ratio
02185
Profitability
Metric | 02185 |
|---|---|
Return on Assets (Normalized) | −7.39% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −8.86% |
Return on Assets
02185
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|@@>$Ckx | LOCK|&^$k@ | $188B | |||
| Medtronic PLC MDT | LOCK|Cr>$!q! | LOCK|P@K$d | $132B | |||
| Stryker Corp SYK | LOCK|$$b#q@n | LOCK|mK | $118B | |||
| Boston Scientific Corp BSX | LOCK|!R#R>V% | LOCK|%V%? | $64B | |||
| Edwards Lifesciences Corp EW | LOCK|<Ntbn%K% | LOCK|Ddz# | $62B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|LfYC>@C | LOCK|p<x | $38B | |||
| DexCom Inc DXCM | LOCK|w<Gb&l@ | LOCK|CVgY | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|@> | LOCK|@D | $30B | |||
| Steris PLC STE | LOCK|tdXc?Np | LOCK|q%LF | $26B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|zzR&S&!& | LOCK|^c< | $20B |
United States